- Event

Asceneuron will present at AD/PD 2023

The Asceneuron team will attend AD/PD 2023, the International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders. from March 28th to April 1st, in Gothenburg, Sweden.
Read more

- Event

Asceneuron to attend Bio-Europe Spring event

Asceneuron's CEO Dirk Beher will attend the Bio Europe Spring partnering event held on March 20-22, 2023 in Basel, Switzerland.
Read more

- Press releases

Ferrer acquires worldwide rights to ASN90, exclusively to treat PSP

Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP)
Read more

- Event

Asceneuron at the Annual Biotech in Europe Forum

Asceneuron will participate in the 22nd Annual Biotech in Europe Forum for global partnering and investment (BEF), being held on September 21st-22nd, 2022 in Basel.
Read more

- Event

Asceneuron at the Latsis Symposium

Asceneuron will present at the Latsis Symposium 2022 organised by the EPFL from August 31st to September 2nd, 2022 in Lausanne.
Read more

- Event

Meet us at the ASBMB OGA Biology Conference!

Asceneuron will present at the ASBMB O-GlcNAc regulation of cellular physiology and pathophysiology conference on July 7–10, 2022 at the University of Georgia, Athens, GA, USA.
Read more

- Press releases

Asceneuron Awarded Grant from The Michael J. Fox Foundation

Asceneuron Awarded Second Grant from The Michael J. Fox Foundation for Accelerated Research into Novel Parkinson’s Disease Therapies
Read more

- Press releases

Asceneuron Publishes Preclinical Efficacy Data on ASN90

Asceneuron Publishes Pioneering Preclinical Efficacy Data on its Novel Clinical Molecule ASN90 in Both Alzheimer’s and Parkinson’s Disease Models
Read more

- Event

Asceneuron to present at the 2nd BrainFit4Life Symposium

Asceneuron will present at the 2nd virtual Symposium organized by BrainFit4Life on November 30th, 2021 from 3pm to 7:30pm CET (9am to 1:30pm EST).
Read more

- Press releases

Asceneuron to Provide Update on O-GlcNAcase Pipeline

Asceneuron to Provide Update on O-GlcNAcase Pipeline at Upcoming Conferences
Read more